Literature DB >> 15759821

Synchronous parathyroid and papillary thyroid carcinoma.

Shi-Dou Lin1, Shih-Te Tu, Shang-Ren Hsu, Julia Heui-Mei Chang, Kuang-Tao Yang, Li-Heng Yang.   

Abstract

Concomitant thyroid disease is not unusual among patients with primary hyperparathyroidism. However, the simultaneous occurrence of parathyroid and thyroid carcinoma is extremely rare. We report a 38-year-old man with primary hyperparathyroidism who presented with osteitis fibrosa cystica complicated with pathologic femoral neck fracture. Preoperative investigation for exclusion of multiple endocrine neoplasia did not find evidence of medullary thyroid carcinoma or pheochromocytoma, but imaging studies revealed the presence of nodules in the right lobe and a parathyroid lesion over the left inferior pole of the thyroid gland. Total thyroidectomy, left parathyroidectomy, and bipolar hemiarthroplasty of the left hip were then performed simultaneously. The resected specimens were pathologically identified as papillary thyroid carcinoma and parathyroid carcinoma, respectively. After the operation, 131I ablation therapy was administered at a dose of 120 mCi. Additional doses of 30 mCi were given yearly as serum thyroglobulin level became elevated. Serum calcium level remained normal during yearly follow-up. Although parathyroid carcinoma is an uncommon cause of parathyroid hormone-dependent hypercalcemia, it should nonetheless be given due consideration because its surgical approach differs from that of parathyroid adenoma. As the coexistence of parathyroid and non-medullary thyroid carcinoma has previously been reported, the possibility of both malignancies must also be considered in the setting of primary hyperparathyroidism with thyroid nodules. If confirmed with preoperative parathyroid scintigraphic and other laboratory studies, an optimal outcome may be achieved with complete resection of both tumors at the time of initial operation, followed by adjunctive therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15759821     DOI: 10.1016/S1726-4901(09)70141-8

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  6 in total

1.  Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism.

Authors:  Melanie Goldfarb; Patrick O'Neal; Judy L Shih; Pamela Hartzband; James Connolly; Per-Olof Hasselgren
Journal:  Endocr Pract       Date:  2009 Jul-Aug       Impact factor: 3.443

2.  A Rare Constellation of Hürthle Cell Thyroid Carcinoma and Parathyroid Carcinoma.

Authors:  Mehrnoosh Zakerkish; Elham Rajaei; Mehrdad Dargahi; Mohammad Bahadoram
Journal:  J Clin Diagn Res       Date:  2015-12-01

Review 3.  Challenges and pitfalls in the management of parathyroid carcinoma: 17-year follow-up of a case and review of the literature.

Authors:  Janneke E Witteveen; Harm R Haak; Job Kievit; Hans Morreau; Johannes A Romijn; Neveen A T Hamdy
Journal:  Horm Cancer       Date:  2010-11-19       Impact factor: 3.869

4.  Synchronous intrathyroidal parathyroid carcinoma and thyroid carcinoma: case report and review of the literature.

Authors:  Nadia De Falco; Giuseppe Santangelo; Fabrizio Chirico; Angelo Cangiano; Maria Giulia Sommella; Angelo Cosenza; Andrea Ronchi; Marina Accardo; Gianluca Pellino; Domenico Parmeggiani; Silvestro Canonico; Massimo De Falco
Journal:  BMC Endocr Disord       Date:  2021-04-07       Impact factor: 2.763

5.  Synchronous parathyroid carcinoma and papillary thyroid carcinoma.

Authors:  Ibtissem Ben Nacef; Dayssem Khelifi; Mehdi Kalthoum; Imen Rojbi; Ines Riahi; Sabrine Mekni; Mamia Ben Salah; Nadia Mchirgui; Karima Khiari
Journal:  Clin Case Rep       Date:  2022-09-24

6.  An Unusual Simultaneous Existence of Parathyroid Carcinoma and Papillary Thyroid Carcinoma: Case Report and Review of Literature.

Authors:  César Ernesto Lam-Chung; Diana Lizbeth Rodríguez-Orihuela; Jazmín De Anda González; Armando Gamboa-Domínguez
Journal:  Case Rep Endocrinol       Date:  2020-03-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.